Our Approach

The team strives to care for patients with sickle cell disease and advance care options by building on the program’s strong foundation and using the resources of Yale, as well as the knowledge of the community. A dedicated 13-bed unit is also available to patients in need of inpatient care. This enables the team to provide continuity of care to patients.

We offer the following services:

• Prescriptions and counseling for pain management
• Disease modifying therapy, including Hydroxyurea, Voxelotor, and L-glutamine, used to treat the underlying cause of sickle cell disease
• Blood transfusions, as needed, to reduce the risk of complications and reduce symptoms
• Attention to kidney problems, iron overload, and infectious diseases
• Referral for regular specialized eye care
• Partnerships with pediatric colleagues to offer curative therapies, including bone marrow transplant and gene therapy